Literature DB >> 15721358

Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.

David E Purdy1, Gwong-Jen J Chang.   

Abstract

DNA plasmids that express flavivirus premembrane/membrane (prM/M) and envelope (E) proteins in the form of virus-like particles (VLPs) have an excellent potential as DNA vaccine candidates against virus infection. The plasmid-expressed VLPs are also useful as safe, noninfectious antigens in serodiagnostic assays. We have constructed plasmids containing the prM/M and E gene regions for DENV-1, -3, and -4 that express and secrete VLPs when electroporated into Chinese hamster ovary cells. Constructs containing the full-length DENV-1 E protein gene did not secrete VLPs into tissue culture fluid effectively. However, a 16-fold increase in ELISA titers of DENV-1 VLPs was achieved after replacing the carboxy-terminal 20% region of DENV-1 E protein gene with the corresponding sequence of Japanese encephalitis virus (JEV). DENV-3 plasmids containing either the full-length DENV-3 E protein gene or the 20% JEV sequence replacement secreted VLPs to similarly high levels. Whereas DENV-4 VLPs were secreted to high levels by plasmids containing the full-length DENV-4 E protein gene but not by the chimeric plasmid containing 20% JEV E replacement. Domain substitutions by replacing prM/M protein stem-anchor region with the corresponding prM/M stem-anchor region of JEV or DENV-2 in the chimeric DENV-4 construct failed to promote the secretion of DENV-4 VLPs. Using the DENV-2 chimeric plasmid with carboxy-terminal 10% of JEV E gene, the sequence responsible for intracellular localization of E protein was mapped onto the E-H1 alpha-helix domain of DENV-2 E protein. Substitution of three amino acids from the DENV-2 sequence to the corresponding amino acids in the JEV sequence (I398L, M401A, and M412L) in the E-H1 was sufficient to promote extracellular secretion and resulted in detectable titers of DENV-2 VLP secretion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721358     DOI: 10.1016/j.virol.2004.12.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

Review 1.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

2.  Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays.

Authors:  Jaimie S Robinson; David Featherstone; Ravi Vasanthapuram; Brad J Biggerstaff; Anita Desai; Nalini Ramamurty; Anwarul Haque Chowdhury; Hardeep S Sandhu; Kathleen F Cavallaro; Barbara W Johnson
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction.

Authors:  Jiraphan Junjhon; Matthawee Lausumpao; Sunpetchuda Supasa; Sansanee Noisakran; Adisak Songjaeng; Prakaimuk Saraithong; Kridsada Chaichoun; Utaiwan Utaipat; Poonsook Keelapang; Amornrat Kanjanahaluethai; Chunya Puttikhunt; Watchara Kasinrerk; Prida Malasit; Nopporn Sittisombut
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

4.  An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.

Authors:  Akane Urakami; Mya Myat Ngwe Tun; Meng Ling Moi; Atsuko Sakurai; Momoko Ishikawa; Sachiko Kuno; Ryuji Ueno; Kouichi Morita; Wataru Akahata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties.

Authors:  Wenquan Liu; Hanning Jiang; Junmei Zhou; Xiaomeng Yang; Yunxia Tang; Danyun Fang; Lifang Jiang
Journal:  Virus Genes       Date:  2009-11-03       Impact factor: 2.332

6.  Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.

Authors:  Derek A Holmes; David E Purdy; Day-Yu Chao; Amanda J Noga; Gwong-Jen J Chang
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

7.  Formation of Virus-Like Particles of the Dengue Virus Serotype 2 Expressed in Silkworm Larvae.

Authors:  Doddy Irawan Setyo Utomo; Ichikawa Hirono; Tatsuya Kato; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

8.  The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase.

Authors:  Melissanne de Wispelaere; Amy J LaCroix; Priscilla L Yang
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Characterization of the GXXXG motif in the first transmembrane segment of Japanese encephalitis virus precursor membrane (prM) protein.

Authors:  Ying-Ju Lin; Jia-Guan Peng; Suh-Chin Wu
Journal:  J Biomed Sci       Date:  2010-05-24       Impact factor: 8.410

10.  Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins.

Authors:  Pei-Gang Wang; Mateusz Kudelko; Joanne Lo; Lewis Yu Lam Siu; Kevin Tsz Hin Kwok; Martin Sachse; John M Nicholls; Roberto Bruzzone; Ralf M Altmeyer; Béatrice Nal
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.